Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

IRIX vs LASE vs ARAY vs ISRG vs GKOS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IRIX
IRIDEX Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$18M
5Y Perf.-57.3%
LASE
Laser Photonics Corporation

Industrial - Machinery

IndustrialsNASDAQ • US
Market Cap$19M
5Y Perf.-66.2%
ARAY
Accuray Incorporated

Medical - Devices

HealthcareNASDAQ • US
Market Cap$45M
5Y Perf.-81.7%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$159.85B
5Y Perf.+140.1%
GKOS
Glaukos Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$7.81B
5Y Perf.+150.8%

IRIX vs LASE vs ARAY vs ISRG vs GKOS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IRIX logoIRIX
LASE logoLASE
ARAY logoARAY
ISRG logoISRG
GKOS logoGKOS
IndustryMedical - DevicesIndustrial - MachineryMedical - DevicesMedical - Instruments & SuppliesMedical - Devices
Market Cap$18M$19M$45M$159.85B$7.81B
Revenue (TTM)$51M$7M$429M$10.58B$551M
Net Income (TTM)$-5M$-8M$-46M$2.98B$-189M
Gross Margin38.0%31.1%26.8%66.3%78.1%
Operating Margin-6.0%-126.5%-3.5%30.5%-15.6%
Forward P/E43.3x
Total Debt$5M$5M$176M$303M$140M
Cash & Equiv.$2M$534K$57M$3.37B$91M

IRIX vs LASE vs ARAY vs ISRG vs GKOSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IRIX
LASE
ARAY
ISRG
GKOS
StockSep 22May 26Return
IRIDEX Corporation (IRIX)10042.7-57.3%
Laser Photonics Cor… (LASE)10033.8-66.2%
Accuray Incorporated (ARAY)10018.3-81.7%
Intuitive Surgical,… (ISRG)100240.1+140.1%
Glaukos Corporation (GKOS)100250.8+150.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: IRIX vs LASE vs ARAY vs ISRG vs GKOS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ISRG leads in 3 of 6 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Glaukos Corporation is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
IRIX
IRIDEX Corporation
The Healthcare Pick

IRIX plays a supporting role in this comparison — it may shine differently against other peers.

Best for: healthcare exposure
LASE
Laser Photonics Corporation
The Industrials Pick

LASE lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: industrials exposure
ARAY
Accuray Incorporated
The Healthcare Pick

Among these 5 stocks, ARAY doesn't own a clear edge in any measured category.

Best for: healthcare exposure
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • beta 1.00
  • 5.5% 10Y total return vs GKOS's 454.5%
  • Lower volatility, beta 1.00, Low D/E 1.7%, current ratio 4.87x
  • Beta 1.00, current ratio 4.87x
Best for: income & stability and long-term compounding
GKOS
Glaukos Corporation
The Growth Play

GKOS is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 32.3%, EPS growth -18.4%, 3Y rev CAGR 21.5%
  • 32.3% revenue growth vs LASE's -13.3%
  • +47.5% vs ARAY's -74.5%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthGKOS logoGKOS32.3% revenue growth vs LASE's -13.3%
Quality / MarginsISRG logoISRG28.2% margin vs LASE's -105.4%
Stability / SafetyISRG logoISRGBeta 1.00 vs ARAY's 2.66, lower leverage
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)GKOS logoGKOS+47.5% vs ARAY's -74.5%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs LASE's -43.1%, ROIC 15.0% vs -42.1%

IRIX vs LASE vs ARAY vs ISRG vs GKOS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IRIXIRIDEX Corporation
FY 2024
Retina
57.2%$28M
Cyclo G Six
26.1%$13M
Product and Service, Other
16.7%$8M
LASELaser Photonics Corporation

Segment breakdown not available.

ARAYAccuray Incorporated
FY 2025
Product
51.8%$238M
Service
48.2%$221M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
GKOSGlaukos Corporation
FY 2019
Glaucoma
97.5%$231M
Corneal Health
2.5%$6M

IRIX vs LASE vs ARAY vs ISRG vs GKOS — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGLASE

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 3 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 1482.0x LASE's $7M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to LASE's -105.4%. On growth, GKOS holds the edge at +41.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…GKOS logoGKOSGlaukos Corporati…
RevenueTrailing 12 months$51M$7M$429M$10.6B$551M
EBITDAEarnings before interest/tax-$2M-$8M-$6M$3.8B-$40M
Net IncomeAfter-tax profit-$5M-$8M-$46M$3.0B-$189M
Free Cash FlowCash after capex-$3M-$4M-$29M$2.8B-$18M
Gross MarginGross profit ÷ Revenue+38.0%+31.1%+26.8%+66.3%+78.1%
Operating MarginEBIT ÷ Revenue-6.0%-126.5%-3.5%+30.5%-15.6%
Net MarginNet income ÷ Revenue-10.0%-105.4%-10.8%+28.2%-34.3%
FCF MarginFCF ÷ Revenue-5.6%-58.7%-6.8%+26.8%-3.4%
Rev. Growth (YoY)Latest quarter vs prior year+7.8%+28.3%-7.4%+23.0%+41.2%
EPS Growth (YoY)Latest quarter vs prior year+25.0%-7.4%-6.1%+18.8%-6.3%
ISRG leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

ARAY leads this category, winning 3 of 4 comparable metrics.

On an enterprise value basis, ARAY's 11.7x EV/EBITDA is more attractive than ISRG's 43.3x.

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…GKOS logoGKOSGlaukos Corporati…
Market CapShares × price$18M$19M$45M$159.8B$7.8B
Enterprise ValueMkt cap + debt − cash$20M$24M$164M$156.8B$7.9B
Trailing P/EPrice ÷ TTM EPS-1.91x-3.97x-24.52x57.19x-40.71x
Forward P/EPrice ÷ next-FY EPS est.43.35x
PEG RatioP/E ÷ EPS growth rate2.63x
EV / EBITDAEnterprise value multiple11.74x43.28x
Price / SalesMarket cap ÷ Revenue0.36x5.68x0.10x15.88x15.40x
Price / BookPrice ÷ Book value/share8.07x1.08x0.48x9.10x11.64x
Price / FCFMarket cap ÷ FCF64.18x
ARAY leads this category, winning 3 of 4 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 7 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-184 for LASE. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRIX's 2.21x. On the Piotroski fundamental quality scale (0–9), ARAY scores 6/9 vs LASE's 1/9, reflecting solid financial health.

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…GKOS logoGKOSGlaukos Corporati…
ROE (TTM)Return on equity-108.7%-183.5%-77.5%+16.9%-26.5%
ROA (TTM)Return on assets-17.9%-43.1%-10.1%+14.8%-20.1%
ROICReturn on invested capital-129.9%-42.1%+3.0%+15.0%-9.2%
ROCEReturn on capital employed-48.8%-45.9%+2.8%+16.5%-10.3%
Piotroski ScoreFundamental quality 0–921663
Debt / EquityFinancial leverage2.21x0.49x2.17x0.02x0.21x
Net DebtTotal debt minus cash$2M$4M$119M-$3.1B$49M
Cash & Equiv.Liquid assets$2M$533,871$57M$3.4B$91M
Total DebtShort + long-term debt$5M$5M$176M$303M$140M
Interest CoverageEBIT ÷ Interest expense-6.60x-0.54x-18.69x
ISRG leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GKOS leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in GKOS five years ago would be worth $17,474 today (with dividends reinvested), compared to $880 for ARAY. Over the past 12 months, GKOS leads with a +47.5% total return vs ARAY's -74.5%. The 3-year compound annual growth rate (CAGR) favors GKOS at 31.5% vs ARAY's -52.7% — a key indicator of consistent wealth creation.

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…GKOS logoGKOSGlaukos Corporati…
YTD ReturnYear-to-date-12.0%-56.3%-55.3%-19.9%+20.6%
1-Year ReturnPast 12 months-9.6%-69.6%-74.5%-16.4%+47.5%
3-Year ReturnCumulative with dividends-54.6%-71.7%-89.4%+48.5%+127.6%
5-Year ReturnCumulative with dividends-86.2%-66.2%-91.2%+61.7%+74.7%
10-Year ReturnCumulative with dividends-90.8%-66.2%-92.8%+549.2%+454.5%
CAGR (3Y)Annualised 3-year return-23.2%-34.4%-52.7%+14.1%+31.5%
GKOS leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ISRG and GKOS each lead in 1 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than ARAY's 2.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GKOS currently trades 91.0% from its 52-week high vs LASE's 12.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…GKOS logoGKOSGlaukos Corporati…
Beta (5Y)Sensitivity to S&P 5001.16x1.81x2.66x1.00x1.16x
52-Week HighHighest price in past year$1.65$6.77$2.10$603.88$146.75
52-Week LowLowest price in past year$0.87$0.38$0.28$427.84$73.16
% of 52W HighCurrent price vs 52-week peak+62.4%+12.9%+18.1%+74.5%+91.0%
RSI (14)Momentum oscillator 0–10041.637.533.543.661.5
Avg Volume (50D)Average daily shares traded124K1.9M1.5M1.8M674K
Evenly matched — ISRG and GKOS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: ISRG as "Buy", GKOS as "Buy". Consensus price targets imply 38.3% upside for ISRG (target: $623) vs 9.8% for GKOS (target: $147).

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…GKOS logoGKOSGlaukos Corporati…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$622.60$146.67
# AnalystsCovering analysts5524
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises2
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+1.4%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARAY leads in 1 (Valuation Metrics). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 2 of 6 categories
Loading custom metrics...

IRIX vs LASE vs ARAY vs ISRG vs GKOS: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is IRIX or LASE or ARAY or ISRG or GKOS a better buy right now?

For growth investors, Glaukos Corporation (GKOS) is the stronger pick with 32.

3% revenue growth year-over-year, versus -13. 3% for Laser Photonics Corporation (LASE). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 57. 2x trailing P/E (43. 3x forward), making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — IRIX or LASE or ARAY or ISRG or GKOS?

Over the past 5 years, Glaukos Corporation (GKOS) delivered a total return of +74.

7%, compared to -91. 2% for Accuray Incorporated (ARAY). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus ARAY's -92. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — IRIX or LASE or ARAY or ISRG or GKOS?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 00β versus Accuray Incorporated's 2. 66β — meaning ARAY is approximately 166% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 2% for IRIDEX Corporation — giving it more financial flexibility in a downturn.

04

Which is growing faster — IRIX or LASE or ARAY or ISRG or GKOS?

By revenue growth (latest reported year), Glaukos Corporation (GKOS) is pulling ahead at 32.

3% versus -13. 3% for Laser Photonics Corporation (LASE). On earnings-per-share growth, the picture is similar: Accuray Incorporated grew EPS 90. 3% year-over-year, compared to -18. 4% for Glaukos Corporation. Over a 3-year CAGR, GKOS leads at 21. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — IRIX or LASE or ARAY or ISRG or GKOS?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -73. 8% for Laser Photonics Corporation — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -189. 3% for LASE. At the gross margin level — before operating expenses — GKOS leads at 77. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is IRIX or LASE or ARAY or ISRG or GKOS more undervalued right now?

Analyst consensus price targets imply the most upside for ISRG: 38.

3% to $622. 60.

07

Which pays a better dividend — IRIX or LASE or ARAY or ISRG or GKOS?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is IRIX or LASE or ARAY or ISRG or GKOS better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), +549. 2% 10Y return). Accuray Incorporated (ARAY) carries a higher beta of 2. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +549. 2%, ARAY: -92. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between IRIX and LASE and ARAY and ISRG and GKOS?

These companies operate in different sectors (IRIX (Healthcare) and LASE (Industrials) and ARAY (Healthcare) and ISRG (Healthcare) and GKOS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: IRIX is a small-cap quality compounder stock; LASE is a small-cap quality compounder stock; ARAY is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock; GKOS is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IRIX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 22%
Run This Screen
Stocks Like

LASE

High-Growth Disruptor

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Gross Margin > 18%
Run This Screen
Stocks Like

ARAY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 16%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

GKOS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 20%
  • Gross Margin > 46%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform IRIX and LASE and ARAY and ISRG and GKOS on the metrics below

Revenue Growth>
%
(IRIX: 7.8% · LASE: 28.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.